mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |